BACCH Laboratories, Inc.
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$810K
Investors
14
Min Invest
None stated
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
What this filing shows
·Every sentence is a value as filed on SEC Form D
BACCH Laboratories, Inc. is a Delaware corporation that first filed a Form D on January 13, 2017 and most recently amended it on July 30, 2025 in the Other Technology industry group. The offering claims Rule 506(b) and covers debt. BACCH Laboratories, Inc. reported $810,000 sold from 14 investors of a $1,000,000 total offering as of the Form D filed July 30, 2025. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 747 Sw 2nd Avenue, Imb#11, Gainesvile, FL 32601.
Critical Disclosures
What the filings and the regulators have said about this entity that a reader should know first. Each line links to its source. The history, the same event across other issuers, and alerts are in the terminal.
Reporting lapsed · Form D · last filing July 30, 2025
Offering declared to continue beyond a year; annual amendment 13+ months overdue An issuer that stops filing is the case the going-concern flag cannot catch: the report that would have carried it was never filed.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
4
latest Jul 30, 2025
Critical / warning
0 / 0
2 watch · 2 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
8
dark, lapsed, closed
Latest event New filer · Jul 30, 2025
SEC.govInvestor
- 4 filing events with values and deltas, latest 2025-07-30, and alerts on the next one
- 8 offering timelines: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
James Mentz
Executive Officer, Director · Gainesville, FL
Richard Allen
Director · Gainesville, FL
Robert Mentz
Executive Officer · Gainesville, FL
Benjamin Andrew Hoover
Director · Gainesville, FL
Garrett Andrew Gleim
Director · Gainesville, FL
Edgar Andrew Choueiri
Executive Officer, Director · Gainesville, FL
Questions About BACCH Laboratories, Inc.
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is BACCH Laboratories, Inc.?
BACCH Laboratories, Inc. is a Delaware corporation that filed a Form D with the SEC on July 30, 2025 in the Other Technology industry group. The filing claims Rule 506(b) for an offering of debt.
Is BACCH Laboratories, Inc. legit?
AltStreet does not rate legitimacy; it reports the public record. BACCH Laboratories, Inc. filed a Form D with the SEC on July 30, 2025 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $810,000 sold to 14 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is BACCH Laboratories, Inc. registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that BACCH Laboratories, Inc. claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has BACCH Laboratories, Inc. raised?
BACCH Laboratories, Inc. reported $810,000 sold from 14 investors of a $1,000,000 total offering as of the Form D filed July 30, 2025.
Who can invest in BACCH Laboratories, Inc.?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.
What is the minimum investment in BACCH Laboratories, Inc.?
The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.
Who is selling BACCH Laboratories, Inc. and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.
Who is behind BACCH Laboratories, Inc.?
The Form D lists 6 related persons: James Mentz, executive officer, director; Richard Allen, director; Robert Mentz, executive officer; Benjamin Andrew Hoover, director; Garrett Andrew Gleim, director; Edgar Andrew Choueiri, executive officer, director. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is BACCH Laboratories, Inc. located?
The issuer's address on its SEC filings is 747 Sw 2nd Avenue, Imb#11, Gainesvile, FL 32601. Its phone number of record is 352-870-3799. It is organized under the laws of Delaware.
How long is the BACCH Laboratories, Inc. offering open?
The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 2 amendments are on record for this CIK.
What is BACCH Laboratories, Inc.'s revenue?
The issuer declined to disclose its revenue range on the Form D, which the form permits.

Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
